Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS England · Body governed by public law
- Suppliers
- Sun Pharma UK Ltd, Accord-UK Ltd SME, Manx Healthcare Ltd SME, Chugai Pharma UK Ltd SME, Napp Pharmaceuticals Ltd SME, Dr Reddy's Laboratories (UK) Ltd SME, Gedeon Richter UK Ltd SME, Teva UK Limited, Merck Sharpe and Dohme (UK) Limited, Celltrion Healthcare United Kingdom Limited, Janssen-Cilag Ltd, Biogen +18 more
- Value
- £39 across 39 lots
- Procedure
- Open procedure
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- Yorkshire and the Humber
- Official notice
- 026491-2024 on Find a Tender
- Timeline
-
- Contract date22 Jul 2024
- Published20 Aug 2024Published 29 days after the contract date
Description
CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Sun Pharma UK Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Accord-UK Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Manx Healthcare Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Chugai Pharma UK Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Napp Pharmaceuticals Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Dr Reddy's Laboratories (UK) Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Gedeon Richter UK Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Teva UK Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Merck Sharpe and Dohme (UK) Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Celltrion Healthcare United Kingdom Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Janssen-Cilag Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Biogen | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Organon Pharmaceuticals UK Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Thornton & Ross SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | GlaxoSmithKline UK Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Takeda UK Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Pfizer Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Zentiva Pharma UK Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Roche Products Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Eli Lilly and Company Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Aventis Pharma Ltd Trading As Sanofi | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Accord-UK Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Celltrion Healthcare United Kingdom Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Orifarm UK | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Galapagos Biotech Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Dr Reddy's Laboratories (UK) Ltd SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Individual supplier | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Biosimilar Collaborations Ireland Limited SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | Sobi (Swedish Orphan Biovitrum Ltd) SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2 | UCB Pharma Ltd (primary) | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/03 - Omalizumab and Diroximel Fumarate for MAE & NOFE - Lot 3 | Biogen | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/03 - Omalizumab and Diroximel Fumarate for MAE & NOFE - Lot 3 | Celltrion Healthcare United Kingdom Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/03 - Omalizumab and Diroximel Fumarate for MAE & NOFE - Lot 3 | Novartis Pharmaceuticals UK Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | AstraZeneca | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Thornton & Ross SME | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | GlaxoSmithKline UK Limited | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Novartis Pharmaceuticals UK Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Eli Lilly and Company Ltd | £1 |
| NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1 | Aventis Pharma t/a Sanofi | £1 |
About the suppliers
Sun Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02992795).
Biogen: every public contract they have won, plus their Companies House record (company 01497267).
Celltrion Healthcare United Kingdom Limited: every public contract they have won, plus their Companies House record (company 11685363).
AstraZeneca: every public contract they have won, plus their Companies House record (company 03674842).
Thornton & Ross: every public contract they have won, plus their Companies House record (company 00185947).
GlaxoSmithKline UK Limited: every public contract they have won, plus their Companies House record (company 04310159).
Novartis Pharmaceuticals UK Ltd: every public contract they have won, plus their Companies House record (company 00119006).
Eli Lilly and Company Ltd: every public contract they have won, plus their Companies House record (company 00284385).
Aventis Pharma t/a Sanofi: every public contract they have won, plus their Companies House record (company 01535640).
Accord-UK Ltd: every public contract they have won, plus their Companies House record (company 00079585).
Manx Healthcare Ltd: every public contract they have won.
Chugai Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02814621).
Napp Pharmaceuticals Ltd: every public contract they have won, plus their Companies House record (company 03690299).
Dr Reddy's Laboratories (UK) Ltd: every public contract they have won, plus their Companies House record (company 01729064).
Gedeon Richter UK Ltd: every public contract they have won, plus their Companies House record (company 04325685).
Teva UK Limited: every public contract they have won, plus their Companies House record (company 00302461).
Merck Sharpe and Dohme (UK) Limited: every public contract they have won, plus their Companies House record (company 00233687).
Janssen-Cilag Ltd: every public contract they have won, plus their Companies House record (company 01027904).
Organon Pharmaceuticals UK Ltd: every public contract they have won.
Takeda UK Ltd: every public contract they have won, plus their Companies House record (company 03362860).
Pfizer Ltd: every public contract they have won, plus their Companies House record (company 00526209).
Zentiva Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02158996).
Roche Products Ltd: every public contract they have won, plus their Companies House record (company 04369760).
Aventis Pharma Ltd Trading As Sanofi: every public contract they have won, plus their Companies House record (company 01535640).
Orifarm UK: every public contract they have won, plus their Companies House record (company 10015046).
Galapagos Biotech Ltd: every public contract they have won.
Biosimilar Collaborations Ireland Limited: every public contract they have won.
Sobi (Swedish Orphan Biovitrum Ltd): every public contract they have won, plus their Companies House record (company 04369760).
UCB Pharma Ltd (primary): every public contract they have won.